Cite
MLA Citation
J. Rytlewski et al.. “P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121).” HemaSphere, vol. 6, n.d., pp. 759–760. http://access.bl.uk/ark:/81055/vdc_100158013693.0x000016